Antitrust Antitrust

Servier, Mylan, Teva spar with EU regulator over patent settlements at bloc's top court

By Nicholas Hirst
  • 20 Oct 2021 12:50
  • 20 Oct 2021 12:50
Les Laboratoires Servier and the European Commission clashed today at the EU's top court over patent settlement deals that prompted hundreds of millions of euros of fines.

The hearing at the EU Court of Justice also involves makers of generic drugs including Mylan, Teva and Lupin.

"Servier, like judges acros

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Nicholas Hirst

Chief Correspondent

Nicholas covers EU merger review and antitrust investigations for Mlex in Brussels. He previously wrote about EU affairs for Politico Europe, European Voice and PaRR. After earning an LLM in European law from the College of Europe in Bruges, he spent a year working in the competition practice of a leading competition law firm in Brussels 2009-10. He graduated in modern European languages from Oxford University in 2006.

Discover MLex

Stay on top of global regulatory developments

Latest News